Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•16/10/2026•16:15 ET
0
Key Highlights
- ➤61,020 shares granted to seven newly hired employees
- ➤17,461 stock options carry a $41.94 exercise price
- ➤43,559 restricted stock units granted under inducement awards
- ➤FDA approved ISEMBLYD in September 2026 for eligible SMA patients
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the Company granted inducement equity awards covering an aggregate of 61,020 shares of its common stock to seven newly hired employees, consisting of inducement stock options to purchase an aggregate of 17,461 shares of common stock and inducement restricted stock units, covering an aggregate of 43,559 shares of its common stock.
Get started
Create a free account to read the full story.